| Product NDC: | 52125-403 |
| Proprietary Name: | Finasteride |
| Non Proprietary Name: | Finasteride |
| Active Ingredient(s): | 5 mg/1 & nbsp; Finasteride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52125-403 |
| Labeler Name: | REMEDYREPACK INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076437 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130514 |
| Package NDC: | 52125-403-02 |
| Package Description: | 30 TABLET in 1 VIAL (52125-403-02) |
| NDC Code | 52125-403-02 |
| Proprietary Name | Finasteride |
| Package Description | 30 TABLET in 1 VIAL (52125-403-02) |
| Product NDC | 52125-403 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Finasteride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130514 |
| Marketing Category Name | ANDA |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | FINASTERIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA] |